The Effectiveness of Telerehabilitation in Liver Transplant Patients
NCT ID: NCT07327008
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
58 participants
INTERVENTIONAL
2026-02-01
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients
NCT01960868
Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients
NCT06615934
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation
NCT02949505
Home-based EXercise and motivAtional Program Before and After Liver Transplantation
NCT07063940
The Effect of Pulmonary Rehabilitation on Cognitive Status in Lung Transplantation Candidates
NCT03528447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation group
The telerehabilitation group will receive videoconference-based telerehabilitation three days a week for eight weeks. All exercises will be performed under the supervision of a physiotherapist.
Telerehabilitation
The telerehabilitation program will include breathing, strengthening, balance, and walking exercises, with increasing intensity week by week, and stretching exercises targeting major muscles will be given during the cool-down period.
Home exercise program group
Home exercise program group will initially be given instructions on the exercises and asked to perform them three days a week for eight weeks. They will be contacted by phone once a week to inquire whether they are doing the exercises.
Home exercise
Patients will be given brochures on breathing, strengthening, balance and walking exercises and asked to perform them without a physiotherapist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehabilitation
The telerehabilitation program will include breathing, strengthening, balance, and walking exercises, with increasing intensity week by week, and stretching exercises targeting major muscles will be given during the cool-down period.
Home exercise
Patients will be given brochures on breathing, strengthening, balance and walking exercises and asked to perform them without a physiotherapist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having had a liver transplant operation at least 6 months prior
* Spontaneous breathing
* Hemodynamic stability
* Reading and writing skills
* Ability to mobilize independently, ability to follow verbal and visual instructions
Exclusion Criteria
* Presence of primary lung disease requiring regular bronchodilator treatment
* Presence of neuromuscular disease or neurological complications
* Musculoskeletal limitation/use of assistive devices
* Being a multiple organ transplant recipient
* Presence of orthopedic disability and functional capacity limitation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alper AYAS
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University-Cerrahpasa, Faculty of Health Sciences, Physiotherapy and Rehabilitation Laboratory
Büyükçekmece, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IUC-FTR-AA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.